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Background: Chronic kidney disease(CKD) plays a critical role in pathogenesis of coronary artery disease(CAD). Even though a lot of studies 
identified risk factors for CAD, factors associated with left main coronary artery disease(LMCAD) remain unclear. We investigated an impact of renal 
insufficiency on LMCAD in patients with stable angina pectoris(SAP).
methods: We performed coronary angiogram to 1601 consecutive patients between 2006 and 2009. A total of 626 consecutive SAP patients with 
significant stenosis and 20 subjects with absolutely normal angiogram as the control group were enrolled. Patients with SAP were divided into two 
groups; LMCAD(n=95) and non-LMCAD(n=531). Significant stenosis was defined as percent luminal reduction > 50% in left main trunk and > 75% 
in the other parts. CKD was defined as an estimated glomerular filtration rate(eGFR) <60 ml/min/1.73 m2 prior to angiography. Major adverse 
cardiovascular events(MACE) was defined such as death, revascularization, admission due to heart failure and stroke. Patients were followed at 2 
year after optimal treatment including coronary revascularization and medication.
results: Among three groups, LMCAD patients had significantly lower eGFR (p<0.001 by ANOVA) and higher presence of dyslipidemia (p=0.02); 
however there were no significant differences in other traditional risk factors, polyunsaturated free fatty acid and brain natriuretic peptide. In SAP 
patients, the presence of LMCAD in patients with CKD was significantly higher than that in patients without CKD(18.5% vs 12.2%, p=0.03). Multiple 
logistic analysis revealed that CKD was independently associated with LMCAD(adjusted odds ratio, 1.74; 95% confidence interval [CI]; 1.09-2.76, 
p=0.01). In patients with LMCAD, MACE in patients with CKD was higher than that in patients without CKD (p<0.02 by Kaplan-Meier analysis). The 
LMCAD patients with CKD had more events compared to the non-LMCAD patients without CKD (hazard ratio 2.45; 95% CI, 1.02 to 5.87, p<0.01).
conclusions: CKD was independently associated with the presence of LMCAD and MACE with LMCAD in SAP patients. Our results suggest that renal 
insufficiency is a residual risk factor in LMCAD patients.
